4.8 Review

The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles

期刊

BIOMATERIALS
卷 30, 期 13, 页码 2591-2597

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2008.12.076

关键词

Lung disease; Nanoparticle therapeutics; Mucus; Mucus penetrating particles; Particle tracking; Rheology

资金

  1. National Institutes of Health [NIH EB003558]
  2. Cystic Fibrosis Foundation [CFF HANES08G0]
  3. National Science Foundation
  4. Croucher Foundation
  5. NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003558] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Highly viscoelastic and adhesive sputum has precluded efficient nanoparticle-based drug and gene delivery to the lungs of patients with cystic fibrosis (CF). We sought to determine whether nanoparticles coated with non-mucoadhesive polymers could penetrate CF sputum, and to use these muco-inert particles (MIPs) as non-destructive nanoprobes to characterize the sputum microstructure. Particles as large as 200 mn in diameter that were densely coated with low MW polyethylene glycol (PEG) moved through undiluted CF sputum with average speeds up to 90-fold faster than similarly-sized uncoated particles. On the other hand, the transport of both coated and uncoated 500 nm particles was strongly hindered. The local viscosity of sputum, encountered by the fastest 10% of 200 nm MIPs, was only 5-fold higher than that of water, whereas the bulk viscosity was 10,000-fold higher at low shear rates. Using measured transport rates of various sized MIPs combined with an obstruction-scaling model, we determined that the average 3D mesh spacing of CF sputum is similar to 140 +/- 50 nm (range; 60-300 nm). Taken together, these results demonstrate that nanoparticles up to 200 mn in diameter that do not adhere to CF sputum can move rapidly through this critical barrier by accessing pores that are filled with a low viscosity fluid. The results also offer hope that desperately needed sputum-penetrating drug- and gene-carrier nanoparticles can be developed for CF. (C) 2009 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据